| Liver enzyme alteration: a guide for clinicians EG Giannini, R Testa, V Savarino Cmaj 172 (3), 367-379, 2005 | 2768 | 2005 |
| Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis E Giannini, F Botta, P Borro, D Risso, P Romagnoli, A Fasoli, MR Mele, ... Gut 52 (8), 1200-1205, 2003 | 715 | 2003 |
| MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study F Botta, E Giannini, P Romagnoli, A Fasoli, F Malfatti, B Chiarbonello, ... Gut 52 (1), 134-139, 2003 | 604 | 2003 |
| Validity and clinical utility of the aspartate aminotransferase–alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus … E Giannini, D Risso, F Botta, B Chiarbonello, A Fasoli, F Malfatti, ... Archives of internal medicine 163 (2), 218-224, 2003 | 558 | 2003 |
| Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival V Santi, F Trevisani, A Gramenzi, A Grignaschi, F Mirici-Cappa, ... Journal of hepatology 53 (2), 291-297, 2010 | 387 | 2010 |
| Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study EG Giannini, A Zaman, A Kreil, A Floreani, P Dulbecco, E Testa, ... Official journal of the American College of Gastroenterology| ACG 101 (11 …, 2006 | 387 | 2006 |
| Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia NH Afdhal, EG Giannini, G Tayyab, A Mohsin, JW Lee, A Andriulli, ... New England Journal of Medicine 367 (8), 716-724, 2012 | 374 | 2012 |
| Progressive liver functional impairment is associated with an increase in AST/ALT ratio E Giannini, F Botta, A Fasoli, P Ceppa, D Risso, PB Lantieri, G Celle, ... Digestive diseases and sciences 44 (6), 1249-1253, 1999 | 333 | 1999 |
| Prognosis of untreated hepatocellular carcinoma EG Giannini, F Farinati, F Ciccarese, A Pecorelli, GL Rapaccini, ... Hepatology 61 (1), 184-190, 2015 | 326 | 2015 |
| Non-invasive diagnosis of advanced fibrosis and cirrhosis S Sharma, K Khalili, GC Nguyen World journal of gastroenterology: WJG 20 (45), 16820, 2014 | 312 | 2014 |
| Thrombocytopenia in chronic liver disease and pharmacologic treatment options EG Giannini Alimentary pharmacology & therapeutics 23 (8), 1055-1065, 2006 | 273 | 2006 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 261 | 2022 |
| EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis E Villa, M Bianchini, A Blasi, A Denys, EG Giannini, A de Gottardi, ... Journal of hepatology 76 (5), 1151-1184, 2022 | 241 | 2022 |
| Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study A Vitale, P Burra, AC Frigo, F Trevisani, F Farinati, G Spolverato, M Volk, ... Journal of hepatology 62 (3), 617-624, 2015 | 241 | 2015 |
| Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy DJ Pinato, SM Murray, A Forner, T Kaneko, P Fessas, P Toniutto, ... Journal for immunotherapy of cancer 9 (9), e003311, 2021 | 198 | 2021 |
| Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease EG Giannini, A Greco, S Marenco, E Andorno, U Valente, V Savarino Clinical Gastroenterology and Hepatology 8 (10), 899-902, 2010 | 198 | 2010 |
| Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis R Testa, R Franceschini, E Giannini, A Cataldi, F Botta, A Fasoli, ... Journal of hepatology 33 (1), 33-37, 2000 | 194 | 2000 |
| Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study A Vitale, RR Morales, G Zanus, F Farinati, P Burra, P Angeli, AC Frigo, ... The lancet oncology 12 (7), 654-662, 2011 | 186 | 2011 |
| An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs HJ Cordell, JJ Fryett, K Ueno, R Darlay, Y Aiba, Y Hitomi, M Kawashima, ... Journal of hepatology 75 (3), 572-581, 2021 | 182 | 2021 |
| Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience F Mirici-Cappa, A Gramenzi, V Santi, A Zambruni, A Di Micoli, M Frigerio, ... Gut 59 (3), 387-396, 2010 | 181 | 2010 |
